Lantheus Holdings, Inc. - Common Stock (LNTH)
92.51
-0.28 (-0.30%)
Lantheus Holdings is a biotechnology company that specializes in developing and commercializing innovative diagnostic imaging agents and therapeutics primarily for oncology and other conditions
Their products include advanced molecular imaging agents that enhance the visualization of diseases in patients, enabling healthcare providers to make more informed decisions about diagnosis and treatment. The company is committed to advancing patient care through its focus on precision medicine, utilizing cutting-edge technologies to improve the detection and management of various diseases, particularly cancers, thus helping clinicians optimize patient outcomes.
Frequently Asked Questions
Is Lantheus Holdings, Inc. - Common Stock publicly traded?
Yes, Lantheus Holdings, Inc. - Common Stock is publicly traded.
What exchange does Lantheus Holdings, Inc. - Common Stock trade on?
Lantheus Holdings, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Lantheus Holdings, Inc. - Common Stock?
The ticker symbol for Lantheus Holdings, Inc. - Common Stock is LNTH on the Nasdaq Stock Market
What is the current price of Lantheus Holdings, Inc. - Common Stock?
The current price of Lantheus Holdings, Inc. - Common Stock is 92.51
When was Lantheus Holdings, Inc. - Common Stock last traded?
The last trade of Lantheus Holdings, Inc. - Common Stock was at 4:00 pm EST on January 31st, 2025
What is the market capitalization of Lantheus Holdings, Inc. - Common Stock?
The market capitalization of Lantheus Holdings, Inc. - Common Stock is 6.25B
How many shares of Lantheus Holdings, Inc. - Common Stock are outstanding?
Lantheus Holdings, Inc. - Common Stock has 67.60M shares outstanding.